482 related articles for article (PubMed ID: 21987677)
1. Protection of retinal ganglion cells and the optic nerve during short-term hyperglycemia in experimental glaucoma.
Ebneter A; Chidlow G; Wood JP; Casson RJ
Arch Ophthalmol; 2011 Oct; 129(10):1337-44. PubMed ID: 21987677
[TBL] [Abstract][Full Text] [Related]
2. Alpha2-adrenoreceptor agonists are neuroprotective in a rat model of optic nerve degeneration.
Yoles E; Wheeler LA; Schwartz M
Invest Ophthalmol Vis Sci; 1999 Jan; 40(1):65-73. PubMed ID: 9888428
[TBL] [Abstract][Full Text] [Related]
3. Rats! Hyperglycemia protects against glaucoma!
McKinnon SJ
Arch Ophthalmol; 2011 Oct; 129(10):1366-7. PubMed ID: 21987681
[No Abstract] [Full Text] [Related]
4. Soluble Nogo-66 receptor prevents synaptic dysfunction and rescues retinal ganglion cell loss in chronic glaucoma.
Fu QL; Liao XX; Li X; Chen D; Shi J; Wen W; Lee DH; So KF
Invest Ophthalmol Vis Sci; 2011 Oct; 52(11):8374-80. PubMed ID: 21948553
[TBL] [Abstract][Full Text] [Related]
5. Time-dependent retinal ganglion cell loss, microglial activation and blood-retina-barrier tightness in an acute model of ocular hypertension.
Trost A; Motloch K; Bruckner D; Schroedl F; Bogner B; Kaser-Eichberger A; Runge C; Strohmaier C; Klein B; Aigner L; Reitsamer HA
Exp Eye Res; 2015 Jul; 136():59-71. PubMed ID: 26001526
[TBL] [Abstract][Full Text] [Related]
6. Retinal ganglion cell loss in a rat ocular hypertension model is sectorial and involves early optic nerve axon loss.
Soto I; Pease ME; Son JL; Shi X; Quigley HA; Marsh-Armstrong N
Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):434-41. PubMed ID: 20811062
[TBL] [Abstract][Full Text] [Related]
7. Axonal protection by 17β-estradiol through thioredoxin-1 in tumor necrosis factor-induced optic neuropathy.
Kitaoka Y; Munemasa Y; Hayashi Y; Kuribayashi J; Koseki N; Kojima K; Kumai T; Ueno S
Endocrinology; 2011 Jul; 152(7):2775-85. PubMed ID: 21586560
[TBL] [Abstract][Full Text] [Related]
8. Blocking LINGO-1 function promotes retinal ganglion cell survival following ocular hypertension and optic nerve transection.
Fu QL; Hu B; Wu W; Pepinsky RB; Mi S; So KF
Invest Ophthalmol Vis Sci; 2008 Mar; 49(3):975-85. PubMed ID: 18326721
[TBL] [Abstract][Full Text] [Related]
9. Lamotrigine monotherapy does not provide protection against the loss of optic nerve axons in a rat model of ocular hypertension.
Marina N; Sajic M; Bull ND; Hyatt AJ; Berry D; Smith KJ; Martin KR
Exp Eye Res; 2012 Nov; 104():1-6. PubMed ID: 22982756
[TBL] [Abstract][Full Text] [Related]
10. Autophagy in axonal degeneration in glaucomatous optic neuropathy.
Munemasa Y; Kitaoka Y
Prog Retin Eye Res; 2015 Jul; 47():1-18. PubMed ID: 25816798
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotection by sodium channel blockade with phenytoin in an experimental model of glaucoma.
Hains BC; Waxman SG
Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4164-9. PubMed ID: 16249495
[TBL] [Abstract][Full Text] [Related]
12. Ocular hypertension impairs optic nerve axonal transport leading to progressive retinal ganglion cell degeneration.
Salinas-Navarro M; Alarcón-Martínez L; Valiente-Soriano FJ; Jiménez-López M; Mayor-Torroglosa S; Avilés-Trigueros M; Villegas-Pérez MP; Vidal-Sanz M
Exp Eye Res; 2010 Jan; 90(1):168-83. PubMed ID: 19835874
[TBL] [Abstract][Full Text] [Related]
13. Chronology of optic nerve head and retinal responses to elevated intraocular pressure.
Johnson EC; Deppmeier LM; Wentzien SK; Hsu I; Morrison JC
Invest Ophthalmol Vis Sci; 2000 Feb; 41(2):431-42. PubMed ID: 10670473
[TBL] [Abstract][Full Text] [Related]
14. Gene therapy with brain-derived neurotrophic factor as a protection: retinal ganglion cells in a rat glaucoma model.
Martin KR; Quigley HA; Zack DJ; Levkovitch-Verbin H; Kielczewski J; Valenta D; Baumrind L; Pease ME; Klein RL; Hauswirth WW
Invest Ophthalmol Vis Sci; 2003 Oct; 44(10):4357-65. PubMed ID: 14507880
[TBL] [Abstract][Full Text] [Related]
15. The effect of hyperglycemia on hypoperfusion-induced injury.
Holman MC; Chidlow G; Wood JP; Casson RJ
Invest Ophthalmol Vis Sci; 2010 Apr; 51(4):2197-207. PubMed ID: 19875663
[TBL] [Abstract][Full Text] [Related]
16. Role of hypoxia-inducible factor-1α in preconditioning-induced protection of retinal ganglion cells in glaucoma.
Zhu Y; Zhang L; Gidday JM
Mol Vis; 2013; 19():2360-72. PubMed ID: 24319330
[TBL] [Abstract][Full Text] [Related]
17. Elevated intracranial pressure causes optic nerve and retinal ganglion cell degeneration in mice.
Nusbaum DM; Wu SM; Frankfort BJ
Exp Eye Res; 2015 Jul; 136():38-44. PubMed ID: 25912998
[TBL] [Abstract][Full Text] [Related]
18. Functional and structural evaluation of lamotrigine treatment in rat models of acute and chronic ocular hypertension.
Sandalon S; Könnecke B; Levkovitch-Verbin H; Simons M; Hein K; Sättler MB; Bähr M; Ofri R
Exp Eye Res; 2013 Oct; 115():47-56. PubMed ID: 23810807
[TBL] [Abstract][Full Text] [Related]
19. Assessment of retinal ganglion cell damage in glaucomatous optic neuropathy: Axon transport, injury and soma loss.
Nuschke AC; Farrell SR; Levesque JM; Chauhan BC
Exp Eye Res; 2015 Dec; 141():111-24. PubMed ID: 26070986
[TBL] [Abstract][Full Text] [Related]
20. Radiation pretreatment does not protect the rat optic nerve from elevated intraocular pressure-induced injury.
Johnson EC; Cepurna WO; Choi D; Choe TE; Morrison JC
Invest Ophthalmol Vis Sci; 2014 Dec; 56(1):412-9. PubMed ID: 25525172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
